Using prescribing health and population data to describe the health of a locality: the development and evaluation of a locality health profile

D.T. Steinke, S. Burney, M. Bennie, S.A. Hudson

Research output: Contribution to journalArticle

Abstract

Objective To develop and evaluate a pharmaco-epidemiological and public health profile that will aid in the determination and evaluation of the health and pharmaceutical needs of a local population with the National Health Service (NHS).

Method Two local health areas (known as local health care co-operatives (LHCCs)) in NHS Lothian with diverse population characteristics had health profiles formally developed using prescribing, hospitalisation and other public health data. The integrated report was able to highlight morbidity issues in each LHCC that could be acted on by either LHCC management or local pharmacy groups. A steering committee and focus groups were used in the design and evaluation process. An evaluation survey of participants including LHCC management, community and LHCC pharmacists and other healthcare professionals was conducted with the main outcome measure being the relative utility of the health profile.

Key findings Participants evaluating the health profiles found them informative and useful in decision making and planning for the locality. Participants anticipated using prescribing data to fill information gaps in other datasets and/or provide a primary care perspective to health in the locality.

Conclusions Health profiles were developed from prescribing health and population data that were shown to be meaningful and useful to local health authority management and other healthcare professionals. The health profiles contained information that could be used to inform decisions or identify areas where further investigation may be required to find out why a particular anomaly is occurring. In Scotland, the focus of a new community pharmacy contract is on the dual elements of chronic disease management and public health contributions, through prevention of disease and/or limitation of disease impact. There is an urgent need to develop tools that help to inform professional interventions involving pharmacists, and thereby improvements to multidisciplinary co-operation. This study suggests a means of describing the population characteristics for informing a network of community pharmacists about public health priorities within their LHCC.

LanguageEnglish
Pages21-30
Number of pages10
JournalInternational Journal of Pharmacy Practice
Volume14
DOIs
Publication statusPublished - 2006

Fingerprint

Health
Health care
Delivery of Health Care
Population
Public health
Public Health
Pharmacists
National Health Programs
Population Characteristics
Health Priorities
Community Health Services
Pharmacies
Scotland
Disease Management
Contracts
Focus Groups
Primary Health Care
Decision Making
Hospitalization
Chronic Disease

Keywords

  • local health care co-operatives
  • population data
  • health profiles

Cite this

@article{6bba5a49ee354cd1b2256d22b8928902,
title = "Using prescribing health and population data to describe the health of a locality: the development and evaluation of a locality health profile",
abstract = "Objective To develop and evaluate a pharmaco-epidemiological and public health profile that will aid in the determination and evaluation of the health and pharmaceutical needs of a local population with the National Health Service (NHS). Method Two local health areas (known as local health care co-operatives (LHCCs)) in NHS Lothian with diverse population characteristics had health profiles formally developed using prescribing, hospitalisation and other public health data. The integrated report was able to highlight morbidity issues in each LHCC that could be acted on by either LHCC management or local pharmacy groups. A steering committee and focus groups were used in the design and evaluation process. An evaluation survey of participants including LHCC management, community and LHCC pharmacists and other healthcare professionals was conducted with the main outcome measure being the relative utility of the health profile. Key findings Participants evaluating the health profiles found them informative and useful in decision making and planning for the locality. Participants anticipated using prescribing data to fill information gaps in other datasets and/or provide a primary care perspective to health in the locality. Conclusions Health profiles were developed from prescribing health and population data that were shown to be meaningful and useful to local health authority management and other healthcare professionals. The health profiles contained information that could be used to inform decisions or identify areas where further investigation may be required to find out why a particular anomaly is occurring. In Scotland, the focus of a new community pharmacy contract is on the dual elements of chronic disease management and public health contributions, through prevention of disease and/or limitation of disease impact. There is an urgent need to develop tools that help to inform professional interventions involving pharmacists, and thereby improvements to multidisciplinary co-operation. This study suggests a means of describing the population characteristics for informing a network of community pharmacists about public health priorities within their LHCC.",
keywords = "local health care co-operatives, population data, health profiles",
author = "D.T. Steinke and S. Burney and M. Bennie and S.A. Hudson",
note = "1 Scottish Executive. Designed to Care: renewing the NHS in Scotland. Edinburgh: Scottish Office Department of Health; December 1997. 2 Scottish Executive. Towards a Healthier Scotland. Edinburgh: Scottish Office Department of Health; February 1999. 3 Gilley J. Meeting the information and budgetary requirements of primary care groups. BMJ 1999;318:168–9. 4 Majeed A. Accurate information may be difficult to produce. BMJ 1999;318:169–70. 5 Improving Health in Scotland: the Challenge. Edinburgh: The Scottish Executive; 2003. 6 The Review of the Public Health Function in Scotland. Edinburgh: The Scottish Executive; 1999. 7 Modernising NHS community pharmacy in Scotland. Consultation paper. Edinburgh: The Scottish Executive; 2004. 8 The Right Medicine: a strategy for pharmaceutical care in Scotland. Edinburgh: The Scottish Executive; 2002. 9 Strom B, editor. Pharmacoepidemiology, 2nd ed. Toronto: Wiley Press; 1994. 10 STATA version 7. Stata Corporation, Texas USA. www. stata.com (accessed 24 October, 2005). 11 Carstairs V. Deprivation and health in Scotland. Health Bull Edinb, 1990;8:162–75. 12 Powell AE, Davies HTO, Thomson RG. Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls. Qual Saf Health Care 2003;112: 122–8. 13 Review of Public Health Function in Scotland. Edinburgh: Scottish Executive; 1999. 14 Asghar MN, Jackson C, Corbett J. Specialist pharmacists in public health: are they the missing link in England? Pharm J 2002;268:22–5. 15 Pharmacy for Health: the way forward for pharmaceutical public health in Scotland. Glasgow: Public Health Institute in Scotland; 2002.",
year = "2006",
doi = "10.1211/ijpp.14.1.0004",
language = "English",
volume = "14",
pages = "21--30",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",

}

TY - JOUR

T1 - Using prescribing health and population data to describe the health of a locality

T2 - International Journal of Pharmacy Practice

AU - Steinke, D.T.

AU - Burney, S.

AU - Bennie, M.

AU - Hudson, S.A.

N1 - 1 Scottish Executive. Designed to Care: renewing the NHS in Scotland. Edinburgh: Scottish Office Department of Health; December 1997. 2 Scottish Executive. Towards a Healthier Scotland. Edinburgh: Scottish Office Department of Health; February 1999. 3 Gilley J. Meeting the information and budgetary requirements of primary care groups. BMJ 1999;318:168–9. 4 Majeed A. Accurate information may be difficult to produce. BMJ 1999;318:169–70. 5 Improving Health in Scotland: the Challenge. Edinburgh: The Scottish Executive; 2003. 6 The Review of the Public Health Function in Scotland. Edinburgh: The Scottish Executive; 1999. 7 Modernising NHS community pharmacy in Scotland. Consultation paper. Edinburgh: The Scottish Executive; 2004. 8 The Right Medicine: a strategy for pharmaceutical care in Scotland. Edinburgh: The Scottish Executive; 2002. 9 Strom B, editor. Pharmacoepidemiology, 2nd ed. Toronto: Wiley Press; 1994. 10 STATA version 7. Stata Corporation, Texas USA. www. stata.com (accessed 24 October, 2005). 11 Carstairs V. Deprivation and health in Scotland. Health Bull Edinb, 1990;8:162–75. 12 Powell AE, Davies HTO, Thomson RG. Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls. Qual Saf Health Care 2003;112: 122–8. 13 Review of Public Health Function in Scotland. Edinburgh: Scottish Executive; 1999. 14 Asghar MN, Jackson C, Corbett J. Specialist pharmacists in public health: are they the missing link in England? Pharm J 2002;268:22–5. 15 Pharmacy for Health: the way forward for pharmaceutical public health in Scotland. Glasgow: Public Health Institute in Scotland; 2002.

PY - 2006

Y1 - 2006

N2 - Objective To develop and evaluate a pharmaco-epidemiological and public health profile that will aid in the determination and evaluation of the health and pharmaceutical needs of a local population with the National Health Service (NHS). Method Two local health areas (known as local health care co-operatives (LHCCs)) in NHS Lothian with diverse population characteristics had health profiles formally developed using prescribing, hospitalisation and other public health data. The integrated report was able to highlight morbidity issues in each LHCC that could be acted on by either LHCC management or local pharmacy groups. A steering committee and focus groups were used in the design and evaluation process. An evaluation survey of participants including LHCC management, community and LHCC pharmacists and other healthcare professionals was conducted with the main outcome measure being the relative utility of the health profile. Key findings Participants evaluating the health profiles found them informative and useful in decision making and planning for the locality. Participants anticipated using prescribing data to fill information gaps in other datasets and/or provide a primary care perspective to health in the locality. Conclusions Health profiles were developed from prescribing health and population data that were shown to be meaningful and useful to local health authority management and other healthcare professionals. The health profiles contained information that could be used to inform decisions or identify areas where further investigation may be required to find out why a particular anomaly is occurring. In Scotland, the focus of a new community pharmacy contract is on the dual elements of chronic disease management and public health contributions, through prevention of disease and/or limitation of disease impact. There is an urgent need to develop tools that help to inform professional interventions involving pharmacists, and thereby improvements to multidisciplinary co-operation. This study suggests a means of describing the population characteristics for informing a network of community pharmacists about public health priorities within their LHCC.

AB - Objective To develop and evaluate a pharmaco-epidemiological and public health profile that will aid in the determination and evaluation of the health and pharmaceutical needs of a local population with the National Health Service (NHS). Method Two local health areas (known as local health care co-operatives (LHCCs)) in NHS Lothian with diverse population characteristics had health profiles formally developed using prescribing, hospitalisation and other public health data. The integrated report was able to highlight morbidity issues in each LHCC that could be acted on by either LHCC management or local pharmacy groups. A steering committee and focus groups were used in the design and evaluation process. An evaluation survey of participants including LHCC management, community and LHCC pharmacists and other healthcare professionals was conducted with the main outcome measure being the relative utility of the health profile. Key findings Participants evaluating the health profiles found them informative and useful in decision making and planning for the locality. Participants anticipated using prescribing data to fill information gaps in other datasets and/or provide a primary care perspective to health in the locality. Conclusions Health profiles were developed from prescribing health and population data that were shown to be meaningful and useful to local health authority management and other healthcare professionals. The health profiles contained information that could be used to inform decisions or identify areas where further investigation may be required to find out why a particular anomaly is occurring. In Scotland, the focus of a new community pharmacy contract is on the dual elements of chronic disease management and public health contributions, through prevention of disease and/or limitation of disease impact. There is an urgent need to develop tools that help to inform professional interventions involving pharmacists, and thereby improvements to multidisciplinary co-operation. This study suggests a means of describing the population characteristics for informing a network of community pharmacists about public health priorities within their LHCC.

KW - local health care co-operatives

KW - population data

KW - health profiles

UR - http://dx.doi.org/10.1211/ijpp.14.1.0004

U2 - 10.1211/ijpp.14.1.0004

DO - 10.1211/ijpp.14.1.0004

M3 - Article

VL - 14

SP - 21

EP - 30

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

ER -